29 July 2023 in Journal of Environmental Sciences
20 October 2023 in Neurochemical Research
24 August 2024 in Food and Chemical Toxicology
2 June 2017 in Journal of Nephropathology
Background: Cyclophosphamide (CP) is amongst the most effective alkylating anticancer drugs which regardless of its harmful side effects including nephrotoxicity, hematotoxicity, mutagenicity and also immunotoxicity, commonly raised for the treatment of a number of cancers and autoimmune ailments. Objectives: This study was undertaken to investigate the ameliorative effect of Lavandula officinalis L extract (LOE) in nephrotoxicity induced by CP in mice. Materials and Methods: In this experimental study, 35 male Swiss albino mice (20–25 g) were randomly divided into 5 groups, each group consist of 7 mice. Mice were pretreated with LOE orally in doses of 100, 200 and 400 mg/kg for 5 consecutive days and CP (200 mg/kg, ip) was administrated on the fifth day 1 hour after the last dose of extract. Then on the sixth day, animals were sacrificed. Blood samples were collected to determine serum creatinine (Cr) and blood urea nitrogen (BUN) levels. Malondialdehyde (MDA), glutathione (GSH) levels and catalase (CAT) and superoxide dismutase (SOD) activity were assayed in kidney tissue. The kidney was maintained in formalin for histological examination. Results: Results showed a significant increase in the levels of MDA, Cr and BUN, and decrease of GSH, CAT and SOD by CP administration. Pre-treatment with LOE showed reduction in the levels of MDA, Cr and BUN and increase of GSH, CAT and SOD in all doses but the most significant alteration was observed at doses of 200 and 400 mg/ kg (P < 0.05). Additionally the nephroprotective effect of the LOE was established by the histological examination of the kidneys. Conclusions: Our results indicated that LOE has produced amelioration in biochemical indices and oxidative stress parameters against CP-induced nephrotoxicity.
16 July 2023 in International Journal of Environmental Health Research
During the outbreak of the novel coronavirus disease 2019 (COVID-19), many countries implemented lockdown policies to control its transmission. These restrictions provided an opportunity to rest and recover the environment. This systematic review (SR) aimed to evaluate the impact of COVID-19 lockdowns on the Air Quality Index (AQI) in countries worldwide. ScienceDirect and PubMed were searched using relevant keywords to identify studies published until March 2020. Overall, 20 studies were included in the SR based on the eligibility criteria. The results show that COVID-19-related lockdown policies positively affect AQI by restricting air-polluting activities, such as transportation, industry, and construction. However, it is important to note that these policies are ineffective in controlling sources of natural air pollution and local dust. The findings of this study emphasize the need for policymakers to approve legislation limiting the sources of air pollutants.
1 January 2025 in Archives of Clinical Infectious Diseases
Background: Candida species are a leading cause of fungal infections worldwide. Candidiasis, the disease caused by Candida, represents a significant public health concern globally. Candida albicans is the most common causative agent, responsible for 50 - 90% of invasive candidiasis cases. Candida albicans employs various virulence factors to adhere to, invade host tissues, and cause disease. Objectives: This study aimed to detect and compare the virulence factors of C. albicans, including hydrophobicity, biofilm formation, ergosterol content, and secretory enzymes, in clinical and environmental samples. Methods: A total of 105 clinical and 165 environmental samples suspected of containing C. albicans were collected from Imam Khomeini Hospital in Ahvaz, Iran. The isolates were evaluated for five potential virulence factors: Ergosterol content, cell surface hydrophobicity (CSH), biofilm formation, protease activity, and phospholipase activity. Results: Sixty C. albicans isolates were identified, consisting of 30 clinical and 30 environmental isolates. Biofilm production was observed in 100% of clinical isolates and 80% of environmental isolates (P < 0.001). Protease activity was detected in 66.6% of clinical isolates and 76.7% of environmental isolates (P = 0.008). Phospholipase activity was present in 60% of clinical isolates and 76.7% of environmental isolates (P = 0.262). Clinical isolates exhibited higher CSH (66.4 ± 9.8) compared to environmental isolates (47.7 ± 17.0) (P < 0.001). The ergosterol content was 1.2 ± 0.5 in clinical isolates and 1.1 ± 0.3 in environmental isolates. Conclusions: Biofilm formation was a consistent characteristic of clinical isolates, while phospholipase and protease activity were more prevalent in environmental C. albicans isolates. The results suggest possible cross-contamination between patients and the environment, as the virulence factors of clinical and environmental isolates were similar.